Find Clinical Trial

Safety and effects on blood pressure of a daily dose of 0.025 to 0.135 milligram per kilogram of S 90652, a paediatric formulation of perindopril, in hypertensive children having received S 90652 – an open, non-comparative, 24-month (minimal duration), multicentre study.


← Back
Study Phase

Phase 2

Therapeutic Area

Cardiovascular Diseases

IndicationHypertension
SponsorInstitut de Recherches Internationales Servier (I.R.I.S)
Active substance/
Medical device

PERINDOPRIL ARGININE,
S090652

Active Substance CodeS090652
Protocol CodeCL2-90652-002
EudraCT Code2005-000474-42
NCT CodeNCT00202592


Documents and links

Results summary READ MORE




Servier Glossary of Terms

To ease the reading, we are developing a glossary of terms. In this glossary, we provide the lay terms used in our lay summaries and the corresponding medical terms. You will find the Servier Glossary of Terms on this link.



© 2022 LES LABORATOIRES SERVIER, an incorporated company of Servier.
All Rights Reserved. Servier does not sell its products over the Internet.
Accessibility